EXACT SCIENCES CORP Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 19 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-08-17: Reporting owner Hoof Torsten; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-07-28: Reporting owner Elliott Jeffrey Thomas; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2020-04-20: Reporting owner Paulsen Gisela; Form 4; Security Restricted Stock Units; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-04-02: Reporting owner Stenhouse Mark; Form 4; Security Restricted Stock Units; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-08-17 | Hoof Torsten Officer (General Manager, International) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +2,551 0 owned after | $0.00 | 2020-08-19 | |
| 2020-07-28 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,750 0 owned after | $0.00 | 2020-07-30 | |
| 2020-04-20 | Paulsen Gisela Officer (Gen Mgr, Precision Oncology) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,267 66,267 owned after | $0.00 | 2020-04-22 | |
| 2020-04-02 | Stenhouse Mark Officer (President, Cologuard) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 25,000 owned after | $0.00 | 2020-04-06 | |
| 2020-02-27 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,025 10,050 owned after | $0.00 | 2020-03-02 | |
| 2020-02-27 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,575 41,150 owned after | $0.00 | 2020-03-02 | |
| 2020-02-26 | Stenhouse Mark Officer (President, Cologuard) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,262 9,789 owned after | $0.00 | 2020-02-28 | |
| 2020-02-26 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,436 10,311 owned after | $0.00 | 2020-02-28 | |
| 2020-02-26 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,025 0 owned after | $0.00 | 2020-02-28 | |
| 2020-02-26 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,312 27,936 owned after | $0.00 | 2020-02-28 | |
| 2020-02-24 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,300 9,300 owned after | $0.00 | 2020-02-26 | |
| 2020-02-24 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −34,325 34,325 owned after | $0.00 | 2020-02-26 | |
| 2020-02-18 | ORVILLE JACOB A Officer (General Manager, New Ventures) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,648 10,946 owned after | $0.00 | 2020-02-20 | |
| 2020-02-15 | Hoof Torsten Officer (General Manager, International) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −877 878 owned after | $0.00 | 2020-03-27 | |
| 2020-02-15 | Hoof Torsten Officer (General Manager, International) | 4 | Restricted Stock Units Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,214 2,429 owned after | $0.00 | 2020-03-27 | |
| 2020-02-14 | Stenhouse Mark Officer (President, Cologuard) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,123 14,123 owned after | $0.00 | 2020-02-18 | |
| 2020-02-14 | ORVILLE JACOB A Officer (General Manager, New Ventures) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,121 8,121 owned after | $0.00 | 2020-02-18 | |
| 2020-02-14 | Elliott Jeffrey Thomas Officer (Chief Financial Officer) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,888 15,888 owned after | $0.00 | 2020-02-18 | |
| 2020-02-14 | Conroy Kevin T Director, Officer (President and CEO) | 4 | Restricted Stock Units Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +124,530 124,530 owned after | $0.00 | 2020-02-18 |